Show simple item record

dc.contributor.authorEsteban, Cristóbal
dc.contributor.authorArostegui Madariaga, Inmaculada ORCID
dc.contributor.authorAramburu, Amaia
dc.contributor.authorMoraza, Javier
dc.contributor.authorAburto, Myriam
dc.contributor.authorAizpiri, Susana
dc.contributor.authorChasco, Leyre
dc.contributor.authorQuintana López, José María
dc.date.accessioned2022-01-27T08:53:52Z
dc.date.available2022-01-27T08:53:52Z
dc.date.issued2022-01
dc.identifier.citationERJ Open Research 8(1) : (2022) // Article ID 00181-2021es_ES
dc.identifier.issn2312-0541
dc.identifier.urihttp://hdl.handle.net/10810/55176
dc.description.abstract[EN] Chronic obstructive pulmonary disease (COPD) is understood as a complex, heterogeneous and multisystem airway obstructive disease. The association of deterioration in health-related quality of life (HRQoL) with mortality and hospitalisation for COPD exacerbation has been explored in general terms. The specific objectives of this study were to determine whether a change in HRQoL is related, over time, to mortality and hospitalisation. Overall, 543 patients were recruited through Galdakao Hospital's five outpatient respiratory clinics. Patients were assessed at baseline, and the end of the first and second year, and were followed up for 3 years. At each assessment, measurements were made of several variables, including HRQoL using the St George's Respiratory Questionnaire (SGRQ). The cohort had moderate obstruction (forced expiratory volume in 1 s 55% of the predicted value). SGRQ total, symptoms, activity and impact scores at baseline were 39.2, 44.5, 48.7 and 32.0, respectively. Every 4-point increase in the SGRQ was associated with an increase in the likelihood of death: "symptoms" domain odds ratio 1.04 (95% CI 1.00-1.08); "activity" domain OR 1.12 (95% CI 1.08-1.17) and "impacts" domain OR 1.11 (95% CI 1.06-1.15). The rate of hospitalisations per year was 5% (95% CI 3-8%) to 7% (95% CI 5-10%) higher for each 4-point increase in the separate domains of the SGRQ. Deterioration in HRQoL by 4 points in SGRQ domain scores over 1 year was associated with an increased likelihood of death and hospitalisation.es_ES
dc.description.sponsorshipThis work was supported by the Spanish Health Research Fund (FIS grant number PI020510), and by funding from the Dept of Health of the Basque Government (grant number 200111002), Spanish Ministry of Economy and Competitiveness (MTM2016-74931-P and BCAM Severo Ochoa excellence accreditation SEV-2017-0718), Dept of Education, Linguistic Policy and Culture of the Basque Government (IT1294-19 and BERC 2018-2021), and the University of the Basque Country (COLAB20/01).es_ES
dc.language.isoenges_ES
dc.publisherEuropean Respiratory Societyes_ES
dc.relationinfo:eu-repo/grantAgreement/MINECO/MTM2016-74931-Pes_ES
dc.relationinfo:eu-repo/grantAgreement/MICIU/SEV-2017-0718es_ES
dc.rightsinfo:eu-repo/semantics/openAccesses_ES
dc.rights.urihttp://creativecommons.org/licenses/by-nc/3.0/es/*
dc.subjectobstructive pulmonary deseasees_ES
dc.subjectexercise capacityes_ES
dc.subjectlung functiones_ES
dc.subjectmortalityes_ES
dc.subjectexacerbationses_ES
dc.subjectquestionnairees_ES
dc.subjectpredictores_ES
dc.subjectmorbidityes_ES
dc.subjectsurvivales_ES
dc.subjectdyspneaes_ES
dc.titleChanges in health-related quality of life as a marker in the prognosis in COPD patientses_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.rights.holder©The authors 2022 This version is distributed under the terms of the Creative nCommons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions@ersnet.orges_ES
dc.rights.holderAtribución-NoComercial 3.0 España*
dc.relation.publisherversionhttps://openres.ersjournals.com/content/8/1/00181-2021es_ES
dc.identifier.doi10.1183/23120541.00181-2021
dc.departamentoesMatemáticases_ES
dc.departamentoeuMatematikaes_ES


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

©The authors 2022
This version is distributed under the terms of the Creative nCommons Attribution Non-Commercial Licence 4.0.
For commercial reproduction rights and permissions contact permissions@ersnet.org
Except where otherwise noted, this item's license is described as ©The authors 2022 This version is distributed under the terms of the Creative nCommons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions@ersnet.org